Sanofi (SNYNF) Change in Receivables (2013 - 2021)

Sanofi (SNYNF) has 4 years of Change in Receivables data on file, last reported at -$149.9 million in Q4 2021.

• Quarterly Change in Receivables fell 2564.53% year-over-year to -$149.9 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $227.5 million (changed N/A YoY) and the FY2025 annual result came in at -$1.4 billion, down 4576.3% from the prior year.
• Change in Receivables declined to -$149.9 million in Q4 2021 per SNYNF's latest filing, from $6.1 million in the prior quarter.
• The five-year high for Change in Receivables was $6.1 million in Q4 2020, with the low at -$149.9 million in Q4 2021.
• Average Change in Receivables over 3 years is -$59.1 million, with a median of -$33.5 million recorded in 2019.
• Year-over-year, Change in Receivables jumped 118.13% in 2020 and plunged 2564.53% in 2021.
• Sanofi's Change in Receivables stood at -$33.5 million in 2019, then jumped by 118.13% to $6.1 million in 2020, then plunged by 2564.53% to -$149.9 million in 2021.
• Business Quant data shows SNYNF's Change in Receivables at -$149.9 million in Q4 2021, $6.1 million in Q4 2020, and -$33.5 million in Q4 2019.